Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Motohiko Osako is active.

Publication


Featured researches published by Motohiko Osako.


Journal of Cardiovascular Pharmacology | 2000

Insulin-like growth factor-I improves recovery of cardiac performance during reperfusion in isolated rat heart by a wortmannin-sensitive mechanism.

Hajime Otani; Tadashi Yamamura; Yoshihisa Nakao; Reiji Hattori; Hideki Kawaguchi; Motohiko Osako; Hiroji Imamura

Insulin-like growth factor-I (IGF-I) has been shown to produce a short-term positive inotropic effect (PIE) in the myocardium under nonischemic conditions. IGF-I also conferred cytoprotection against ischemia and reperfusion injury in various organs. IGF-I may, therefore, facilitate the recovery of postischemic cardiac function. Isolated and crystalloid-perfused rat heart was subjected to 25 min of normothermic ischemia followed by 30 min of reperfusion. IGF-I produced PIE in a dose-dependent manner at concentrations ranging between 1 and 100 nM under nonischemic conditions. Although 1 nM isoproterenol produced much greater PIE and myocardial energy conversion efficiency (MECE) than did 65 nM IGF-I in this condition, the same concentration of IGF-I administered during reperfusion conferred better recovery of left ventricular function and MECE compared with isoproterenol. The improved cardiac performance by IGF-I was associated with lower release of creatine kinase (CK). Wortmannin (100 nM), a specific inhibitor of phosphatidylinositol kinase (PI-3 kinase), abrogated IGF-I-induced improvement of contractile function and inhibition of CK release in the postischemic heart. We conclude that IGF-I administered during reperfusion accelerates recovery of cardiac performance and mitigates myocardial injury through a wortmannin-sensitive mechanism.


Antioxidants & Redox Signaling | 2001

Dual Involvement of Coenzyme Q10 in Redox Signaling and Inhibition of Death Signaling in the Rat Heart Mitochondria

Tadashi Yamamura; Hajime Otani; Yoshihisa Nakao; Reiji Hattori; Motohiko Osako; Hiroji Imamura; Dipak K. Das

Coenzyme Q10 (CoQ) has long been utilized as a cardioprotective agent in various heart diseases. One of the most important mechanisms by which CoQ exerts cardioprotection is aerobic ATP production as a mobile electron carrier in the mitochondrial electron transfer chain. The ability of CoQ to afford myocardial protection is also attributed to its antioxidant property. However, CoQ may also act as a pro-oxidant through the generation of reactive oxygen species. Although excess oxidative stress is known to induce death signaling via cytochrome c release from mitochondria, it is now apparent that a brief exposure to oxidative stress stimulates redox signaling for acquisition of tolerance to oxidative stress. Therefore, we have investigated dual involvement of CoQ in redox signaling generation through enhanced production of reactive oxygen species and death signaling inhibition through antioxidation. Mitochondria were isolated from the rat heart and incubated with CoQ (10 or 100 microM) or its vehicle HCO 60 for 1 h. H2O2 and cytochrome c release from respiring mitochondria were increased by antimycin A (2 microM), an inhibitor of complex III respiratory chain, or by high Ca2+ (10 microM). This enhanced release of H2O2 was associated with an increase in lipid peroxidation as measured with 4-hydroxy-2-nonenal-modified proteins and with large amplitude swelling of mitochondria. CoQ potentiated H2O2 release from antimycin A- or high Ca(2+)-treated mitochondria, but was capable of inhibiting lipid peroxidation and large amplitude swelling, and attenuated cytochrome c release from the mitochondria. In addition, CoQ increased ATP synthesis by mitochondria. These results suggest that CoQ plays dual roles in mitochondrial generation of intracellular signaling. CoQ acts as a pro-oxidant that participates in redox signaling. CoQ also acts as an antioxidant that inhibits permeability transition and cytochrome c release, and increases ATP synthesis, thereby attenuating death signaling toward apoptosis and necrosis.


The Annals of Thoracic Surgery | 2000

Fate of fibrin sealant in pericardial space

Reiji Hattori; Hajime Otani; Hideyasu Omiya; Shigeru Tabata; Yoshihisa Nakao; Tadashi Yamamura; Motohiko Osako; Yukihito Saito; Hiroji Imamura

BACKGROUND Although fibrin sealant (Beriplast, Aventis Behring, Marburg, Germany) has been widely used as a supplementary measure for hemostasis during cardiac surgery in Europe and is becoming popular in the United States, the pharmocokinetics of fibrin sealant applied in pericardial space has not been elucidated. METHODS A small incision was made on the epicardial surface of the left ventricle of a rat, and the incision was sutured. Total 0.2 ml of fibrin sealant containing iodine 125 (125I)-labeled fibrinogen, aprotinin, blood coagulation factor XIII and thrombin was applied to the area around the suture line. RESULTS Distributions of 125I-labeled fibrinogen in the heart on postoperative days 1, 3, 7, and 14 were 48.2% +/- 1.8%, 20.7% +/- 2.2%, 0.15% +/- 0.02%, and 0.01% +/- 0.02%, respectively. The radioactivity was negligible in the blood, liver, spleen, and kidney except for the thyroid in which the radioactivity increased to 7.9% +/- 0.7% and 4.3% +/- 0.4%, respectively, on postoperative days 7 and 14. Iodine 125-labeled fibrinogen concentrations of the heart and other organs showed a similar change in the time course of distribution. Dense and thick fibrin network, observed on postoperative day 1, had dissipated and was thinner with collagen formation by postoperative day 7. CONCLUSIONS Fibrin sealant applied to the pericardial cavity regresses rapidly and plays an important role in wound healing.


Clinical and Experimental Pharmacology and Physiology | 2000

Effects Of The Na+/H+ Exchange Inhibitor Cariporide (HOE 642) On Cardiac Function And Cardiomyocyte Cell Death In Rat Ischaemic–Reperfused Heart

Hajime Otani; Takamichi Uchiyama; Tadashi Yamamura; Yoshihisa Nakao; Reiji Hattori; Hideki Ninomiya; Masakuni Kido; Hideki Kawaguchi; Motohiko Osako; Hiroji Imamura

1. Na+/H+ exchange has been implicated in the mechanism of reperfusion injury. We examined the effects of the cardiac‐specific Na+/H+ exchange inhibitor cariporide (HOE 642) on postischaemic recovery of cardiac function and cardiomyocyte cell death (i.e. necrosis and apoptosis).


The Japanese Journal of Thoracic and Cardiovascular Surgery | 2001

Experimental study of pulmonary artery infusion with cisplatin in a solitary pulmonary tumor model using a rat colorectal adenocarcinoma cell line

Hideyasu Omiya; Yukihito Saito; Reiji Hattori; Motohiko Osako; Hiroji Imamura

OBJECTIVES We assessed a tumor model prepared by open lung injection to study metastatic lung tumors, and evaluated the efficacy of pulmonary artery infusion. METHODS Subjects were 30 male F344 rats. In experiment 1, we evaluated chemosensitivity of a rat colorectal adenocarcinoma cell line (RCN-9) using a colorimetric [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. In experiment 2, we injected RCN-9 cells into the left lung on day 0; on day 10, we measured tumor tissue blood flow before and after pulmonary arterial occlusion. In experiment 3, we injected RCN-9 cells into the left lung and conducted no further procedures in controls. The pulmonary artery infusion group underwent pulmonary artery infusion with 0.1 mg of cisplatin on day 3 and the sham group injection with saline solution alone. On day 10, rats were sacrificed and maximum tumor cross-section measured. RESULTS In experiment 1, the drug concentration required to inhibit cell growth 50% was 2.45 x 10(-6) M. In experiment 2, tumor tissue blood flow decreased significantly after arterial occlusion (p = 0.003). In experiment 3, the maximum tumor cross-section in the pulmonary artery infusion group was significantly smaller than in shams (p = 0.0027) and controls (p = 0.0019). CONCLUSIONS The pulmonary artery supplies tumors with blood, so this model appears useful in studying metastatic lung tumors, whose size was reduced significantly by pulmonary artery infusion with cisplatin. Pulmonary artery infusion is thus a promising modality in metastatic lung tumor treatment.


The Journal of Thoracic and Cardiovascular Surgery | 2000

Potential role of vacuolar H+–adenosine triphosphatase in neointimal formation in cultured human saphenous vein☆

Hajime Otani; Hideyasu Ohmiya; Reiji Hattori; Hirofumi Fujii; Hideki Ninomiya; Masakuni Kido; Hideki Kawaguchi; Motohiko Osako; Hiroji Imamura; Tetsuo Ohta; Shoji Ohkuma

OBJECTIVE Vacuolar H(+)-adenosine triphosphatase plays a pivotal role in pH regulation and molecular transport across the vacuolar membranes and is involved in cell proliferation and transformation. In the present study, possible involvement of vacuolar H(+)-adenosine triphosphatase in neointimal formation was investigated in an organ culture model of human saphenous vein. METHODS AND RESULTS Cultured saphenous vein segments developed neointimal formation and marked thickening of the media within 14 days. Neointimal formation and medial thickening were completely inhibited by 10 nmol/L bafilomycin A(1), a selective inhibitor of vacuolar H(+)-adenosine triphosphatase, although structurally related macrolide antibiotics FK-506 and erythromycin were without an effect. The neointimal cells were positive for alpha-smooth muscle actin and vimentin but negative for desmin, indicative of myofibroblasts. The emergence of myofibroblasts was inhibited, and endothelial cells were preserved in the saphenous vein segments treated with bafilomycin A(1). Uptake of bromodeoxyuridine, a proliferation marker, by myofibroblasts was abrogated in the saphenous vein segments treated with 10 nmol/L bafilomycin A(1). Detection of apoptotic cells by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling concomitant with identification of desmin-expressing smooth muscle cells demonstrated that neointimal myofibroblasts, but not medial smooth muscle cells, that expressed desmin underwent apoptosis by treatment with bafilomycin A(1). CONCLUSIONS These results suggest that vacuolar H(+)-adenosine triphosphatase may be involved in myofibroblast growth that contributes to neointimal formation and medial thickening in cultured human saphenous vein. Increased sensitivity of myofibroblasts, but not endothelial cells, and differentiated smooth muscle cells to bafilomycin A(1) may have potential therapeutic implications in the treatment for vein graft disease.


The Japanese Journal of Thoracic and Cardiovascular Surgery | 1998

One stage operation for aneurysm of the diverticulum of the ductus arteriosus and coronary artery bypass grafting

Masakuni Kido; Hideki Kawaguchi; Hideki Ninomiya; Motohiko Osako; Hajime Otani; Hiroji Imamura

Aneurysm of the diverticulum of the ductus arteriosus in the adult is rare. One stage operation for aneurysm of the diverticulum of the ductus arteriosis and coronary artery bypass grafting (CABG) is reported. A 61-year-old man was admitted for diagnosis of thoracic aneurysm on chest X-ray and CT. Chest CT scan showed an aneurysm above the left main pulmonary artery. An aortography showed the left vertebral artery originated directly from the aortic arch and a saccular aneurysm arising from the aortic isthmus and lesser curvature of the aortic arch. Coronary arteriography showed 75% stenosis at the right coronary artery (seg. #1) and 75% stenosis at the left anterior descending artery. Operation was performed through a median sternotomy. The aneurysm of 6 to 3 cm was located between the aortic isthmus and left pulmonary artery. Ascending aorta and right atrium were used to institute cardiopulmonary bypass (CPB). CABG (LITA to #7, SVG to #4 PD) was performed. Arterial cannulation was then switched to the left femoral artery. The proximal aorta was cross-clamped between the left vertebral artery and the left subclavian artery under the partial CPB, and the distal aorta was occluded with a occulusive balloon catheter via the right femoral artery. The selective left axillar artery cannulation was performed to perfuse LITA. The aneurysm was resected and closed with a patch. His post-operative course was uneventful.


The Japanese Journal of Thoracic and Cardiovascular Surgery | 2018

Off-pump coronary artery bypass grafting in a tracheostomy patient

Mio Kasai; Motohiko Osako; Toshiyuki Yamada; Kentaro Yamabe

In patients who have undergone laryngectomy and have a tracheal stoma, a full median sternotomy substantially increases the risk of wound infection, osteomyelitis, mediastinitis, bleeding, tracheal injury, and poor wound healing. Several reports have been published on sternotomies and skin incisions in tracheostoma patients. Transverse bilateral thoracosternotomy, T-shaped partial sternotomy (manubrium-sparing sternotomy) with transverse skin flaps and anterolateral thoracotomy with partial sternotomy are described as successful approaches to the mediastinum for cardiac surgery. We present a successful case in which off-pump coronary artery bypass grafting (CABG) was performed in a tracheostoma patient using a low T-shaped partial sternotomy and the PAS-Port system. Good long-term results were achieved.


The Annals of Thoracic Surgery | 2018

A Calcified Amorphous Tumor Originating in the Aortic Valve Cusp

Mio Kasai; Motohiko Osako; Tomoyuki Tanino; Arafumi Maeshima

Calcified amorphous tumor (CAT) of the heart is a rare nonneoplastic cardiac tumor. The clinical features of cardiac CATs resemble those of other cardiac tumors that include symptoms related to obstruction or embolization. Cardiac CATs have been found in all chambers of the heart but predominantly present in the left ventricle, mitral annulus, and mitral valve. Here we report an extremely rare case of CAT originating in the aortic valve cusp, which may be related to aortic annular calcification and aortic valve stenosis. We successfully treated this patient with tumor resection and aortic valve replacement.


Journal of Artificial Organs | 2002

Reliability and efficacy of a monitoring system for an implanted pulse generator

Motohiko Osako; Tadashi Sato; Hirofumi Fujii; Tomohiko Sumita; Hiroyoshi Fujiwara; Yoshihisa Nakao; Takashi Miyamoto; Chiharu Enoki; Hajime Otani; Hiroji Imamura

Abstract The Selection 900/900E is a physiological pacing device with a sophisticated monitoring system for detecting and analyzing atrial arrhythmias. We have investigated the reliability and efficacy of the Selection monitoring system. Twelve patients with episodes of atrial tachyarrhythmias were implanted the with Selection device (7 men, 5 women, aged 73 ± 6 years old). Ten patients had sick sinus syndrome and two patients had a high degree of atrioventricular (AV) block. All patients underwent 24-h external Holter monitoring after the operation (136 ± 41 days) to evaluate the accuracy of the data recorded by the internal monitoring system. There was no significant difference in counter data between the 24-h external Holter and the internal monitoring systems. Four patients recorded an episode of atrial fibrillation by both systems. In two patients, the 24-h external Holter monitoring system misread DDI pacing after mode switching as sinus rhythm or pacing failure. In another patient, the featured function of this pacing device for atrial tachyarrhythmia was recognized as a sensing failure by the 24-h external Holter monitoring system. The Selection 900/900E monitoring system is a reliable and informative way to evaluate the relevance of pacing therapy.

Collaboration


Dive into the Motohiko Osako's collaboration.

Top Co-Authors

Avatar

Hajime Otani

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar

Hiroji Imamura

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar

Hirofumi Fujii

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar

Yoshihisa Nakao

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hideki Ninomiya

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar

Reiji Hattori

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar

Masakuni Kido

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar

Hideyasu Omiya

Kansai Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge